Citryll
Citryll is pioneering treatments for immune-mediated inflammatory diseases targeting Neutrophil Extracellular Traps with CIT-013.
$92.5M Series B+ ·
Led by Forbion Capital Partners · Source: fundraisingfox.com
Total raised: $113.38M across 2 sourced rounds
All 2 rounds ↓Signals
Website registeredSep 27, 2012 (14 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $92.5M | fundraisingfox.com | ||
| Series B+ | $20.88M | finsmes.com |
Timeline
- Website created
Founders and team
HV
Helmuth van Es FounderRC
Renato Chirivi co-founderLinkedIn · source: citryll.comEM
Eric Meldrum Chief Scientific Offcier & Interim CEOMK
Maarten Kraan Chief Medical Officer
Investors
BBioGeneration Ventureslead investor
BBOM
BBrightGene
CCurie Capital
FForbion Capital Partnerslead investor
JJohnson & Johnson Innovationlead investor
- MModiQuest B.V.
NNovartis Venture Fundlead investor
PPureos Bioventures
SSeventure Partnerslead investor
Companies like Citryll
BBionyra$165M Series A · Jun 2026
MMirador Therapeutics$250M Series B+ · Jan 2026
SSudo Bio$37M Series A · Sep 2022
TTinkeso TherapeuticsKKhartis Therapeutics$95M Series B+ · Aug 2026
OOuro Medicines$120M Series A · Jan 2025
Other companies backed by Forbion Capital Partners
OOMass Therapeutics$310M Series B+ · Oct 2026
KKynexis$112.57M Series A · Aug 2026
RRQ Bio$115M Series A · Jun 2026
CCellCentric$220M Series B+ · May 2026
TTropic Biosciences$105M Series B+ · Mar 2026
SSidera Bio$109.99M Series A · Nov 2025
Forbion Capital Partners portfolio →
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/citryll (get a free API key).